Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy E Purvis

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cell Systems|January 20, 2022
The structure of the human cell cycleWayne Stallaert, Katarzyna M Kedziora, Colin D Taylor, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Non-Genetic Mechanisms of Fractional Resistance to Abemaciclib in Dedifferentiated LiposarcomaLauryn E Bailey, Samuel C Wolff, Tarek M Zikry, et al.
Cell Systems|November 20, 2021
The structure of the human cell cycleWayne Stallaert, Katarzyna M Kedziora, Colin D Taylor, et al.
Molecular Pharmacology|May 15, 2010
A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cellsParag P Shah, Tianhua Wang, Rachel L Kaletsky, et al.
Molecular Systems Biology|March 20, 2019
Evidence that the human cell cycle is a series of uncoupled, memoryless phasesHui Xiao Chao, Randy I Fakhreddin, Hristo K Shimerov, et al.
Molecular Systems Biology|September 26, 2022
The molecular architecture of cell cycle arrestWayne Stallaert, Sovanny R Taylor, Katarzyna M Kedziora, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2024
Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cellsTarek M Zikry, Samuel C Wolff, Jolene S Ranek, et al.
Nature Communications|September 21, 2019
Genetic determinants of cellular addiction to DNA polymerase thetaWanjuan Feng, Dennis A Simpson, Juan Carvajal-Garcia, et al.
Molecular Pharmacology|April 12, 2008
Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin LParag P Shah, Michael C Myers, Mary Pat Beavers, et al.
NAR Cancer|January 1, 2021
Dual inhibition of DNA-PK and DNA polymerase theta overcomes radiation resistance induced by p53 deficiencyRashmi J Kumar, Hui Xiao Chao, Dennis A Simpson, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cell Systems|January 20, 2022
The structure of the human cell cycleWayne Stallaert, Katarzyna M Kedziora, Colin D Taylor, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Non-Genetic Mechanisms of Fractional Resistance to Abemaciclib in Dedifferentiated LiposarcomaLauryn E Bailey, Samuel C Wolff, Tarek M Zikry, et al.
Cell Systems|November 20, 2021
The structure of the human cell cycleWayne Stallaert, Katarzyna M Kedziora, Colin D Taylor, et al.
Molecular Pharmacology|May 15, 2010
A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cellsParag P Shah, Tianhua Wang, Rachel L Kaletsky, et al.
Molecular Systems Biology|March 20, 2019
Evidence that the human cell cycle is a series of uncoupled, memoryless phasesHui Xiao Chao, Randy I Fakhreddin, Hristo K Shimerov, et al.
Molecular Systems Biology|September 26, 2022
The molecular architecture of cell cycle arrestWayne Stallaert, Sovanny R Taylor, Katarzyna M Kedziora, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2024
Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cellsTarek M Zikry, Samuel C Wolff, Jolene S Ranek, et al.
Nature Communications|September 21, 2019
Genetic determinants of cellular addiction to DNA polymerase thetaWanjuan Feng, Dennis A Simpson, Juan Carvajal-Garcia, et al.
Molecular Pharmacology|April 12, 2008
Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin LParag P Shah, Michael C Myers, Mary Pat Beavers, et al.
NAR Cancer|January 1, 2021
Dual inhibition of DNA-PK and DNA polymerase theta overcomes radiation resistance induced by p53 deficiencyRashmi J Kumar, Hui Xiao Chao, Dennis A Simpson, et al.
Pageof 6